Schonfeld Strategic Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-118,775	Closed	-$2.42M	–	2247
2025 Q2	$2.42M	Buy	+118,775	New	+$2.31M	0.02%	882
2024 Q3	–	Sell	-119,629	Closed	-$4.43M	–	2085
2024 Q2	$4.43M	Buy	+119,629	New	+$4.51M	0.03%	591
2024 Q1	–	Sell	-130,542	Closed	-$5.18M	–	2103
2023 Q4	$5.18M	Buy	+130,542	New	+$3.84M	0.03%	507
2023 Q1	–	Sell	-14,266	Closed	-$636K	–	2164
2022 Q4	$636K	Buy	+14,266	New	+$509K	0.01%	1397
2022 Q2	–	Sell	-14,100	Closed	-$481K	–	2595
2022 Q1	$481K	Buy	14,100 +457	+3%	+$14.6K	﹤0.01%	1399
2021 Q4	$527K	Sell	13,643 -43,164	-76%	-$1.88M	﹤0.01%	1235
2021 Q3	$3.07M	Sell	56,807 -20,073	-26%	-$942K	0.03%	570
2021 Q2	$2.57M	Buy	76,880 +42,310	+122%	+$1.16M	0.03%	636
2021 Q1	$712K	Buy	+34,570	New	+$794K	0.01%	1020